Barclays Maintains an 'Equalweight' on Human Genome Sciences (HGSI); Looking At $15/Share For GSK To Seal The Deal
Go back to Barclays Maintains an 'Equalweight' on Human Genome Sciences (HGSI); Looking At $15/Share For GSK To Seal The Deal| GLAXOSMITHKLINE PLC (NYSE: GSK) | Delayed: 49.52 -0.48 (0.96%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $50.00 | 52 Week High | $45.58 | |||
| Open | $49.04 | 52 Week Low | $37.82 | |||
| Day High | $49.57 | P/E | N/A | |||
| Day Low | $48.86 | EPS | $0.00 | |||
| Volume | 3,722,991 | |||||
| Human Genome Sciences, Inc. (NASDAQ: HGSI) | Delayed: 14.24 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.24 | 52 Week High | $16.58 | |||
| Open | $55.80 | 52 Week Low | $6.51 | |||
| Day High | $14.24 | P/E | N/A | |||
| Day Low | $14.24 | EPS | $-1.79 | |||
| Volume | 557,147 | |||||
